Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Snakin-Z from jujube fruits may help treat Alzheimer's due to its enzyme inhibition and antioxidant properties.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

An arthritis drug helped a person with severe hair loss regrow their hair.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Alitretinoin can effectively treat frontal fibrosing alopecia.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

The gel effectively reduced folliculitis symptoms and was safe to use.

New anti-acne medications are being tested to offer alternatives to current treatments.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

30% supramolecular salicylic acid is safe and effective for treating mild to moderate facial acne.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.